G Ferrante, M Nakano, F Prati, G Niccoli… - Circulation, 2011 - Am Heart Assoc References 1. Ferrante G, Nakano M, Prati F, Niccoli G, Mallus MT, Ramazzotti V, Montone RA, Kolodgie FD, Virmani R, Crea F. High levels of systemic myeloperoxidase are associated with coronary plaque erosion in patients with acute coronary syndromes: a ...
[HTML] from nih.govWH Tang, Y Wu, SJ Nicholls… - Clinical chemistry, 2011 - Am Assoc Clin Chem RESULTS: The median plasma MPO concentration was 101 pmol/L (interquartile range 68–187 pmol/L). Patients with plasma MPO concentrations >322 pmol/L (14.6% of population) had increased risk of developing future MACEs [hazard ratio (HR) 1.78, 95% CI 1.33–2.37, P < 0.001], ... Cited by 3 - Related articles - All 5 versions
Y Nazligul, M Aslan, M Horoz, Y Celik… - Clinical …, 2011 - Elsevier Myeloperoxidase activity has been investigated after eradication of Helicobacter pylori (H.pylori) in infected patients in previous studies but the results are controversial. The aim of this study was to the effect on serum myeloperoxidase activity and oxidative status of ... All 2 versions
AK Tiden, T Sjogren, M Svensson, A Berlind… - Journal of Biological …, 2011 - ASBMB Anna-Karin Tidén§, Tove Sjögren¶, Mats Svensson#, Alexandra Bernlind#, Revathy Senthilmohan*, Francoise Auchère*, Henrietta Norman#, Per-Olof Markgren#, Susanne Gustavsson#, Staffan Schmidt#, Stefan Lundquist#, Louisa V Forbes*, Nicholas J ...
O Skaff, DI Pattison, PE Morgan… - The Biochemical …, 2011 - ncbi.nlm.nih.gov Elevated myeloperoxidase (MPO) levels are associated with multiple human inflammatory pathologies. MPO catalyzes the oxidation of Cl-, Br- and SCN- by H2O2 to generate the powerful oxidants hypochlorous acid (HOCl), hypobromous acid (HOBr) and hypothiocyanous acid ...
G Ferrante, M Nakano, F Prati, G Niccoli… - Circulation, 2011 - Am Heart Assoc References 1. Ferrante G, Nakano M, Prati F, Niccoli G, Mallus MT, Ramazzotti V, Montone RA, Kolodgie FD, Virmani R, Crea F. High levels of systemic myeloperoxidase are associated with coronary plaque erosion in patients with acute coronary syndromes: a ...
[HTML] from nih.govWH Tang, Y Wu, SJ Nicholls… - Clinical chemistry, 2011 - Am Assoc Clin Chem RESULTS: The median plasma MPO concentration was 101 pmol/L (interquartile range 68–187 pmol/L). Patients with plasma MPO concentrations >322 pmol/L (14.6% of population) had increased risk of developing future MACEs [hazard ratio (HR) 1.78, 95% CI 1.33–2.37, P < 0.001], ... Cited by 3 - Related articles - All 5 versions
Y Nazligul, M Aslan, M Horoz, Y Celik… - Clinical …, 2011 - Elsevier Myeloperoxidase activity has been investigated after eradication of Helicobacter pylori (H.pylori) in infected patients in previous studies but the results are controversial. The aim of this study was to the effect on serum myeloperoxidase activity and oxidative status of ... All 2 versions
AK Tiden, T Sjogren, M Svensson, A Berlind… - Journal of Biological …, 2011 - ASBMB Anna-Karin Tidén§, Tove Sjögren¶, Mats Svensson#, Alexandra Bernlind#, Revathy Senthilmohan*, Francoise Auchère*, Henrietta Norman#, Per-Olof Markgren#, Susanne Gustavsson#, Staffan Schmidt#, Stefan Lundquist#, Louisa V Forbes*, Nicholas J ...
O Skaff, DI Pattison, PE Morgan… - The Biochemical …, 2011 - ncbi.nlm.nih.gov Elevated myeloperoxidase (MPO) levels are associated with multiple human inflammatory pathologies. MPO catalyzes the oxidation of Cl-, Br- and SCN- by H2O2 to generate the powerful oxidants hypochlorous acid (HOCl), hypobromous acid (HOBr) and hypothiocyanous acid ...
G Ferrante, M Nakano, F Prati, G Niccoli… - Circulation, 2011 - Am Heart Assoc References 1. Ferrante G, Nakano M, Prati F, Niccoli G, Mallus MT, Ramazzotti V, Montone RA, Kolodgie FD, Virmani R, Crea F. High levels of systemic myeloperoxidase are associated with coronary plaque erosion in patients with acute coronary syndromes: a ...
[HTML] from nih.govWH Tang, Y Wu, SJ Nicholls… - Clinical chemistry, 2011 - Am Assoc Clin Chem RESULTS: The median plasma MPO concentration was 101 pmol/L (interquartile range 68–187 pmol/L). Patients with plasma MPO concentrations >322 pmol/L (14.6% of population) had increased risk of developing future MACEs [hazard ratio (HR) 1.78, 95% CI 1.33–2.37, P < 0.001], ... Cited by 3 - Related articles - All 5 versions
Y Nazligul, M Aslan, M Horoz, Y Celik… - Clinical …, 2011 - Elsevier Myeloperoxidase activity has been investigated after eradication of Helicobacter pylori (H.pylori) in infected patients in previous studies but the results are controversial. The aim of this study was to the effect on serum myeloperoxidase activity and oxidative status of ... All 2 versions
AK Tiden, T Sjogren, M Svensson, A Berlind… - Journal of Biological …, 2011 - ASBMB Anna-Karin Tidén§, Tove Sjögren¶, Mats Svensson#, Alexandra Bernlind#, Revathy Senthilmohan*, Francoise Auchère*, Henrietta Norman#, Per-Olof Markgren#, Susanne Gustavsson#, Staffan Schmidt#, Stefan Lundquist#, Louisa V Forbes*, Nicholas J ...
O Skaff, DI Pattison, PE Morgan… - The Biochemical …, 2011 - ncbi.nlm.nih.gov Elevated myeloperoxidase (MPO) levels are associated with multiple human inflammatory pathologies. MPO catalyzes the oxidation of Cl-, Br- and SCN- by H2O2 to generate the powerful oxidants hypochlorous acid (HOCl), hypobromous acid (HOBr) and hypothiocyanous acid ...
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
安全保密
